Is Eli Lilly using ‘granfluencers’ to raise awareness of its Alzheimer’s med?
By
Marc Iskowitz
Sep 04, 2024
Here’s why older internet celebs — granfluencers — soon might be making rounds on the Alzheimer’s drug marketing scene.
SGLT-2 inhibitors may cut dementia risk in patients with diabetes
By
Haymarket Media
Sep 03, 2024
The findings show a greater effect with longer treatment, compared with dipeptidyl peptidase-4 inhibitors.
Studies highlight increasing dementia deaths, contributing factors to diagnosis and cognitive decline
By
Kimberly Bonvissuto
Aug 16, 2024
More people are dying from dementia, and location and demographics are among the factors that may contribute to not only a dementia diagnosis, but also to how quickly someone will experience cognitive...
Risk for Alzheimer’s dementia lower with treated versus untreated HTN
Aug 14, 2024
The all-cause dementia risk was greater for those with treated and untreated hypertension compared with healthy controls.
Plasma biomarkers of Alzheimer’s neuropathy linked to dementia risk
Aug 01, 2024
Significant associations were seen for all Alzheimer’s disease plasma biomarkers in late life with late-life dementia.
New practices, strategies help improve life for those with dementia, caregivers: report
By
Kimberly Bonvissuto
Jul 26, 2024
New practices and strategies are helping senior living communities improve the everyday lives of residents living with dementia and their caregivers, according to a new report from Sodexo that aims to...
State budget has ‘positive steps’ but does not do enough for providers, residents, groups say
By
Lois A. Bowers
Jul 22, 2024
Senior living industry advocates in Pennsylvania say they are encouraged by steps to support older adults evident in the recently passed state budget, but they say much more needs to be done to support...
FDA clears nasal spray for moderate Alzheimer’s disease in first patient
By
Donna Shryer
Jul 16, 2024
Two recent developments in Alzheimer’s disease research offer new hope for patients and their families. Among these, in June, Tiziana Life Sciences received Food and Drug Administration clearance...
New report calls for more research on women’s health issues
Jul 12, 2024
The National Academies of Sciences, Engineering and Medicine analysis noted that women are disproportionately affected by chronic illnesses, including Alzheimer’s disease, depression and osteoporosis.
More news for Wednesday, July 3, 2024
By
Kimberly Bonvissuto
Jul 03, 2024
Sonida Senior Living acquires 9 communities, to manage 2 more … FDA approves donanemab treatment for early Alzheimer’s disease … House subcommittee advances proposal to cut HUD funding by 7% …...